Literature DB >> 14747533

The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes.

Rongtuan Lin1, Ryan S Noyce, Susan E Collins, Roger D Everett, Karen L Mossman.   

Abstract

Virus infection induces a rapid cellular response in cells characterized by the induction of interferon. While interferon itself does not induce an antiviral response, it activates a number of interferon-stimulated genes that collectively function to inhibit virus replication and spread. Previously, we and others reported that herpes simplex virus type 1 (HSV-1) induces an interferon -independent antiviral response in the absence of virus replication. Here, we report that the HSV-1 proteins ICP0 and vhs function in concert to disable the host antiviral response. In particular, we show that ICP0 blocks interferon regulatory factor IRF3- and IRF7-mediated activation of interferon-stimulated genes and that the RING finger domain of ICP0 is essential for this activity. Furthermore, we demonstrate that HSV-1 modifies the IRF3 pathway in a manner different from that of the small RNA viruses most commonly studied.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747533      PMCID: PMC369457          DOI: 10.1128/jvi.78.4.1675-1684.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  97 in total

1.  Herpes simplex virus triggers and then disarms a host antiviral response.

Authors:  K L Mossman; P F Macgregor; J J Rozmus; A B Goryachev; A M Edwards; J R Smiley
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 2.  Interferon activation and innate immunity.

Authors:  C Le Page; P Génin; M G Baines; J Hiscott
Journal:  Rev Immunogenet       Date:  2000

Review 3.  IRF family of transcription factors as regulators of host defense.

Authors:  T Taniguchi; K Ogasawara; A Takaoka; N Tanaka
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  Multiple regulatory domains control IRF-7 activity in response to virus infection.

Authors:  R Lin; Y Mamane; J Hiscott
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

Review 5.  Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures.

Authors:  S Goodbourn; L Didcock; R E Randall
Journal:  J Gen Virol       Date:  2000-10       Impact factor: 3.891

6.  ICP0 induces the accumulation of colocalizing conjugated ubiquitin.

Authors:  R D Everett
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 7.  Interferon-induced antiviral actions and their regulation.

Authors:  G C Sen; R M Ransohoff
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

8.  Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1.

Authors:  Mary Jane Nicholl; Laurence H Robinson; Chris M Preston
Journal:  J Gen Virol       Date:  2000-09       Impact factor: 3.891

9.  A new pathway of translational regulation mediated by eukaryotic initiation factor 3.

Authors:  J Guo; D J Hui; W C Merrick; G C Sen
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

10.  Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3.

Authors:  M J Servant; B ten Oever; C LePage; L Conti; S Gessani; I Julkunen; R Lin; J Hiscott
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

View more
  138 in total

Review 1.  Herpes simplex virus type 1 persists in the aged brain through hypothetical expression of accessory genes.

Authors:  Isamu Mori
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

2.  The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-κB in dendritic cells in the absence of type I interferon signaling.

Authors:  Christopher R Cotter; Won-keun Kim; Marie L Nguyen; Jacob S Yount; Carolina B López; John A Blaho; Thomas M Moran
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Mechanisms of autoinhibition of IRF-7 and a probable model for inactivation of IRF-7 by Kaposi's sarcoma-associated herpesvirus protein ORF45.

Authors:  Narayanan Sathish; Fan Xiu Zhu; Ellis E Golub; Qiming Liang; Yan Yuan
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

4.  Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5.

Authors:  Junji Xing; Shuai Wang; Rongtuan Lin; Karen L Mossman; Chunfu Zheng
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

5.  Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3.

Authors:  Huifang Zhu; Chunfu Zheng; Junji Xing; Shuai Wang; Shuping Li; Rongtuan Lin; Karen L Mossman
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

6.  Characterization of a potent refractory state and persistence of herpes simplex virus 1 in cell culture.

Authors:  Cristina Barreca; Peter O'Hare
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

7.  Herpes simplex virus 1 serine/threonine kinase US3 hyperphosphorylates IRF3 and inhibits beta interferon production.

Authors:  Shuai Wang; Kezhen Wang; Rongtuan Lin; Chunfu Zheng
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

8.  HSV ICP0 recruits USP7 to modulate TLR-mediated innate response.

Authors:  Sandrine Daubeuf; Divyendu Singh; Yaohong Tan; Hongiu Liu; Howard J Federoff; William J Bowers; Khaled Tolba
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

9.  Attenuation of the adaptive immune response in rhesus macaques infected with simian varicella virus lacking open reading frame 61.

Authors:  Christine Meyer; Amelia Kerns; Kristen Haberthur; Jesse Dewane; Joshua Walker; Wayne Gray; Ilhem Messaoudi
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

10.  Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism.

Authors:  Esra Fakioglu; Sarah S Wilson; Pedro M M Mesquita; Ehsan Hazrati; Natalia Cheshenko; John A Blaho; Betsy C Herold
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.